UnitedHealth Group Redeemable noncontrolling interests in subsidiaries decreased by 11.4% to $1.42B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 67.3%, from $4.36B to $1.42B. Over 5 years (FY 2020 to FY 2025), Redeemable noncontrolling interests in subsidiaries shows a downward trend with a -6.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase represents a potential future cash obligation that could impact liquidity or capital allocation.
This represents the portion of equity in a subsidiary that is held by third parties but is subject to redemption feature...
Specific to companies with complex joint venture or subsidiary structures; peers with similar structures will report this similarly.
other_redeemable_noncontrolling_interest_equity_carrying_amount| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.30B | $1.37B | $1.43B | $1.52B | $4.92B | $4.86B | $4.90B | $4.80B | $4.79B | $4.42B | $4.50B | $4.55B | $4.56B | $4.57B | $4.32B | $4.36B | $4.32B | $4.24B | $1.61B | $1.42B |
| QoQ Change | — | +5.7% | +4.4% | +5.9% | +224.0% | -1.3% | +0.8% | -2.0% | -0.3% | -7.8% | +1.9% | +1.1% | +0.2% | +0.4% | -5.5% | +0.8% | -1.0% | -1.6% | -62.1% | -11.4% |
| YoY Change | — | — | — | — | +278.9% | +253.8% | +241.5% | +216.1% | -2.7% | -9.1% | -8.1% | -5.3% | -4.8% | +3.6% | -3.9% | -4.2% | -5.3% | -7.2% | -62.8% | -67.3% |